Table 1.

Demographic and Clinical Characteristics

Characteristic	Total (N=563)	CrAg Positive (N=32)	CrAg Negative (N=531)	p- value
Demographics
Female gender	301	16 (50%)	285 (54%)	0.69
Median age (years)	33 (28–40)	36 (29–41)	33 (28–39)	0.42
HIV History
Prior known HIV infection	375	17 (53%)	358 (67%)	0.10
Median CD4-count (cells/uL)	51 (16–171)	25 (8–77)	55 (18–172)	0.02
ART on admission	104	4 (13%)	100 (19%)	0.37
Co-trimoxazole on admission	273	13 (41%)	260 (49%)	0.36
Fluconazole on admission	0	0	0	NA
Fluconazole at discharge *	6	2 (7%)	4 (1%)	0.002
Presenting symptoms**
Fever	493	29 (91%)	464 (87%)	0.59
Weight loss >5 kg	409	21 (66%)	388 (73%)	0.36
Dyspnea	315	18 (56%)	297 (56%)	0.97
Final diagnosis
Tuberculosis	337	10 (31%)	327 (62%)	0.001
Unknown diagnosis	96	8 (25%)	88 (16%)	0.22

Data presented as number (%) or median (interquartile range)

^*Fluconazole use at discharge only known for 520 patients

^**Cough present in 100% (parent study inclusion criteria)